My cover from "Platinum(IV)-Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple-Negative Breast Cancer Models" was officially published today. 🔥
Special thanks to co-author Dr. José Pedro Cerón-Carrasco (@jpcer0n) for the art. #SLAP 🦸🏻♀️🦸🏽♀️💥
I got published as co-author. ☄️
I am grateful for the opportunity given to work on this project.
Particularly, I want to congratulate ‘first author’ Dr. @AfrujaAhad who published this outstanding work and defended successfully her thesis in a one-week period. Enjoy the read.🔥
Congrats to Afruja and rest of team members at BC and MSKCC! Great collaboration with the Lewis group.! Impressive results in vivo for a gold based ADC, very exciting!! @AfrujaAhad @LewisLabMSKCC @BCCancerCenter @GC_CUNY https://t.co/sgrXqDWtpg
Platinum(IV)-gold(I) agents with promising anticancer activity: Selected studies in 2D and 3D triple-negative breast cancer models (Contel et al. @ContelLab @javoed_@naznayeem @AfrujaAhad@jpcer0n@IgnacioELeon@CUNY) https://t.co/Q9u2n4nq5E
My first author article is officially out in Chemistry- A European Journal as Hot Paper 🔥. Enjoy the read!
Thanks to my PI @ContelLab for all the guidance and all co-authors for the contribution to the article.
@GC_BiochemPhD@GC_CUNY@ChemEurJ
https://t.co/A0utmZOydr
Our latest mini review in Curr. Opin. Chem. Biol. and first article for doctoral student Javier Lopez-Hernandez! Promising heterometallic compounds as anticancer agents: Recent studies in vivo - ScienceDirect @javoed_ @BCCancerCenter https://t.co/gGv2nIRqej
My first review article just got published online. All thanks to @ContelLab for the continuous support. I am very happy! Enjoy the reading.
@ElsevierConnect
https://t.co/LkdyU35c5P